 |
인쇄하기
취소
|
Novartis Korea holds launching symposium for Exelon patch
The launching symposium for Exelon Patch (rivastigmine transdermal patch) was held in Cheju, it was announced on December 18.
“Exelon is a cholinesterase inhibitor, and it is thought to exert its therapeutic effect by enhancing cholinergic function,” said Professor Clive Ballard of King’s College in UK.
He said it inhibits the cholinesterase enzyme from breaking down acetylcholine, increa...
“Exelon is a cholinesterase inhibitor, and it is thought to exert its therapeutic effect by enhancing cholinergic function,” said Professor Clive Ballard of King’s College in UK.
He said it inhibits the cholinesterase enzyme from breaking down acetylcholine, increa...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.